However, induction of autophagy has also been reported in response to MEK inhibition in models of KRASG12D-driven lung cancer with loss of LKB1 expression (Bhatt et al., 2023), suggesting that LKB1 is dispensable for increases in autophagy in lung cancer. The gene discussed is MAP2K7; the disease is lung carcinoma.